Amneal Pharmaceuticals Class A stock price

엠닐 파머슈티컬스NASDAQ:AMRX · Nasdaq · Healthcare
$20.30+1.15%
2026-10-02 close
Loading chart…

Today's signals · Near 52-week high, MA aligned

Signal details →

Amneal Pharmaceuticals Class A last closed at $20.30 (+1.15%) on 2026-10-02. Signals today: Near 52-week high, MA aligned. Listed on Nasdaq. Trailing 12 months PER is 42.3×. Its overall grade ranks 260 of 739 stocks in Healthcare.

About this company

Amneal Pharmaceuticals Class A last closed at $20.30 (+1.15%) on 2026-10-02. Signals today: Near 52-week high, MA aligned. Listed on Nasdaq.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall B+ · 260/739

Valuation grade D

Details →

Related stocks

  • Teva Pharmaceutical IndustriesCompetitor

    제네릭·특수의약품 분야에서 직접 경쟁

  • ViatrisCompetitor

    미국 및 글로벌 제네릭 시장의 주요 경쟁사

  • Sandoz GroupCompetitor

    제네릭 및 바이오시밀러 중심의 대형 경쟁사

Details →

ETFs holding this stock

Allspring SMID Core ETF · Invesco DWA SmallCap Momentum ETF

Details →
About Amneal Pharmaceuticals Class A
What technical signals does Amneal Pharmaceuticals Class A (AMRX) have?
Amneal Pharmaceuticals Class A current technical signals: MA alignment (score 0.79).
Is Amneal Pharmaceuticals Class A a cup-and-handle pattern?
No. Amneal Pharmaceuticals Class A has no valid Cup signal right now.
What published figures are available for Amneal Pharmaceuticals Class A?
Market cap: $6.38B. Trailing 12 months PER: 42.3×. Latest quarter PBR: 56.94×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Major stocks in the same sector

2026-10-03 dataset

Turn what you saw on this name into a strategy

Ask Q about Amneal Pharmaceuticals Class A, or open the plan table on the main site.

From the names you found, through to a scheduled run

Set the conditions and they run at the scheduled time (live orders are not open yet).

See plans ↗

Amneal Pharmaceuticals Class A notifications

Quantus Signal · live data · not investment advice · Privacy Policy